Shady Macaron, MD, a bariatric surgeon with Trinity Health of New England, says that his patients admit they dont like needles but use an injectable GLP-1 anyway because they like the results
For instance, in June 2025, Novo Nordisk launched its weight-loss drug Wegovy in India
PMID: 15282464, DOI: 10.1016/j.jtcvs.2003.12.014
Semaglutide (Ozempic, Wegovy) is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist, while tirzepatide (Mounjaro, Zepbound) is a dual-acting glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 agonist
Whether you are just beginning to research your options or you are ready to take the next step, this comprehensive guide will walk you through what tirzepatide treats, realistic expectations for your weight loss timeline, and what the full treatment experience looks like when you partner with our expert clinical team